Can Flecainide Cause Bradycardia? | When Slow Pulse Matters

Flecainide can slow electrical signals in the heart, and that slowdown can lead to a low heart rate or pauses in certain people.

Flecainide is prescribed to steady certain fast rhythms, most often atrial fibrillation or atrial flutter. It works by slowing conduction through heart tissue. That’s the intended effect. In some bodies, the same “slow the signal” action can slow things too much.

If you’ve noticed a lower pulse after starting flecainide, or an ECG report mentioned “sinus bradycardia” or “AV block,” you’re in the right place. You’ll learn why it can happen, what makes it more likely, and what steps usually come next.

What Bradycardia Means And When It Becomes A Problem

Bradycardia means a heart rate that’s slower than typical. Many reports flag a resting rate under 60 beats per minute as bradycardia. The number alone doesn’t decide risk. Symptoms decide it.

When a slow rate reduces blood flow, people may feel lightheaded, faint, unusually tired, short of breath, or “off” in a hard-to-name way. Mayo Clinic’s bradycardia symptoms list also calls out urgent warning signs like fainting, trouble breathing, or chest pain that lasts more than a few minutes.

How Flecainide Can Slow The Heart

Flecainide is a class Ic antiarrhythmic. It blocks sodium channels in heart cells, slowing conduction. On an ECG, that can show up as longer PR intervals and a wider QRS complex. The signal takes longer to travel.

This is useful when you’re trying to prevent rapid, disorganized activity. It can be a problem when the heart’s built-in pacemaker (the sinus node) is already weak, or when the “wiring” between the atria and ventricles doesn’t pass signals cleanly. In those settings, flecainide can tip a borderline system into bradycardia, pauses, or higher-grade AV block.

Can Flecainide Cause Bradycardia?

Yes. Flecainide can be linked with bradycardia in a few ways: it can slow sinus node firing, slow AV conduction, and unmask conduction disease that wasn’t obvious before treatment. The DailyMed prescribing information states that flecainide should be used with extreme caution in people with sick sinus syndrome because it may cause sinus bradycardia, sinus pause, or sinus arrest.

Many people take flecainide and never develop a clinically meaningful slow rate. Your odds depend on your baseline conduction system, dose, kidney and liver function, and whether you also take other rate-slowing medicines.

Flecainide Bradycardia Risk With A Real-World Modifier

“Risk” can feel vague, so here are patterns clinicians watch for because they raise the odds that flecainide will slow the heart too much. If one fits you, it doesn’t mean flecainide is wrong. It means monitoring and dose decisions deserve more attention.

• Sinus node disease. A history of sick sinus syndrome, pauses, or a slow rate that won’t rise with activity.
• Baseline AV block or bundle branch block. A longer PR interval, prior second-degree AV block, or a wide QRS before starting.
• Reduced kidney function. Flecainide is cleared in part by the kidneys, so levels can climb if clearance drops.
• Other rate-slowing drugs. Beta blockers, certain calcium channel blockers, digoxin, and some antiarrhythmics can stack effects.
• Electrolyte shifts. Low potassium or magnesium can make conduction and rhythm less stable.

What To Track At Home If You’re On Flecainide

You don’t need fancy gear to give your care team useful clues. A few notes can save time and guesswork.

• Resting pulse trend. Your usual resting range before flecainide, then the new range after starting or changing dose.
• Symptoms tied to readings. A pulse of 48 with no symptoms may be fine for you. A pulse of 58 with dizziness is not.
• Timing. Note how long after a dose symptoms start, and whether they fade before the next dose.

If you use a wearable, treat the trend as a clue, not a diagnosis. Wearables can miss beats or misread irregular rhythms. Your clinician can confirm with an ECG or an ambulatory monitor.

Common Situations That Can Mimic Flecainide Bradycardia

Not every slow pulse on flecainide is caused by flecainide. These patterns come up often.

Slow Rates During Sleep Or In Trained Athletes

Most people slow down at night, and some fit people run slow at rest. If your lowest numbers show up overnight and you feel normal in the daytime, that pattern can be benign.

Medication “Stacking”

Flecainide often gets paired with an AV-nodal blocker to prevent atrial flutter from conducting 1:1. If you also take a beta blocker or diltiazem, dose changes can push the combined effect too far.

Higher Flecainide Exposure

Dehydration, kidney changes, or dosing errors can raise levels. As levels rise, conduction slows more, and ECG intervals can stretch. That’s one reason follow-up ECG checks are common after dose changes.

How Clinicians Decide If A Low Rate Is “Ok”

A single low pulse reading is less useful than your symptom picture. The 2018 ACC/AHA/HRS bradycardia guideline notes there isn’t a fixed minimum heart rate or pause duration that automatically calls for a pacemaker in sinus node dysfunction. The decision depends on symptoms and on linking those symptoms to the slow rhythm.

That approach fits medication-related bradycardia too. If a slow rate is present but you feel well, the plan may be watchful monitoring. If you’re dizzy, fainting, or can’t function, the plan needs to move.

Situation	Why It Can Lead To Bradycardia	Typical Next Step
Sick sinus syndrome or prior pauses	Sinus node already fires slowly; flecainide can slow it further	Closer ECG monitoring, dose review, pacing discussion if symptomatic
Baseline PR prolongation or AV block	AV conduction is sluggish; added slowing can trigger higher-grade block	Repeat ECG, consider lower dose or alternate agent
Bundle branch block or wide QRS	Intraventricular conduction is delayed; flecainide can widen QRS more	ECG checks after changes; reassess if QRS widens a lot
Kidney function decline	Drug clearance drops; levels rise and conduction slows more	Renal labs, dose adjustment, added monitoring
Drug stacking (beta blocker, diltiazem, digoxin)	Multiple agents slow conduction or node firing	Adjust the combination based on ECG and symptoms
Electrolyte imbalance	Low potassium or magnesium can destabilize conduction	Correct electrolytes, recheck ECG
Accidental extra dose or dosing confusion	Peak levels spike; conduction slows more than intended	Urgent guidance; ECG assessment
Underlying ischemic disease or LV dysfunction	Class Ic drugs are less safe in these settings	Recheck indication; consider alternate rhythm plan

Testing That Clarifies The Cause

When bradycardia shows up on flecainide, clinicians usually confirm two things: what your rhythm is doing and whether flecainide is driving it.

Electrocardiogram

An ECG can show sinus bradycardia, pauses, PR prolongation, QRS widening, or AV block patterns. It also gives a baseline to compare after a dose change.

Ambulatory Monitoring

If symptoms come and go, a Holter monitor, patch monitor, or loop recorder can capture events you won’t see in a short clinic ECG.

What Usually Fixes Flecainide-Linked Bradycardia

The fix depends on the mechanism. Many cases improve with medication changes.

Adjusting Dose Or Stopping The Drug

If bradycardia clusters near peak dosing times, timing details help. If the rate is too low or pauses show up, prescribers often lower the dose or stop flecainide.

Reviewing The Medication Stack

Rate-slowing partners can be the tipping point. Sometimes the AV-nodal blocker dose gets trimmed while flecainide stays the same. Sometimes it’s the opposite. The ECG and symptom pattern guide the call.

Switching Rhythm Strategy

If flecainide is causing conduction trouble, other rhythm-control options may fit better, including different antiarrhythmics or ablation in selected patients. The ACC flecainide considerations sheet flags avoidance in ischemic heart disease or left ventricular dysfunction, since those settings carry higher proarrhythmia risk.

Pacemaker In Select Cases

If someone needs rhythm control but has symptomatic sinus node dysfunction or AV block that won’t tolerate it, pacing can be part of the plan.

What You Notice	What It Can Mean	What To Do Next
New dizziness or lightheaded spells	Rate too low for your needs, or pauses	Call your prescriber the same day; ask if you need an ECG soon
Fainting or near-fainting	Possible pauses or high-grade block	Urgent evaluation today
Breathlessness with a low pulse	Low output, medication stacking, or rhythm change	Same-day call; check blood pressure if you can
Chest pain that lasts more than a few minutes	Needs emergency assessment	Emergency services
Slow pulse only during sleep	Sleep-related slowing can be normal	Track trend; mention at next visit if you feel well
Pulse drops right after a dose increase	Peak level effect	Call prescriber; do not self-adjust without guidance
New “missed beats” feeling with a slow pulse	Pauses, ectopy, or rhythm shift	Ask about ambulatory monitoring

Red Flags That Shouldn’t Wait

Seek urgent care for fainting, severe shortness of breath, or chest pain that persists. The symptoms list linked earlier is a solid checklist if you’re unsure what counts as urgent.

If you suspect an extra dose, or you have severe weakness, confusion, or a new slow pulse with low blood pressure, treat it as urgent. Bring your medication list, the dose, and the timing of your last dose.

How To Lower Risk While Staying On Therapy

If you and your prescriber decide flecainide still fits your rhythm goals, small habits can reduce surprises.

• Take doses on schedule. Dose clustering can spike levels and shift conduction.
• Share your full medication list. Include over-the-counter cold meds, supplements, and new prescriptions.
• Get follow-up ECGs when asked. ECG changes can show up before symptoms do.

Flecainide is a strong option for the right patient. If bradycardia shows up, it often signals a need to re-check fit, dose, and medication pairing. The goal is a steady rhythm without trading it for a slow rate that makes you feel worse.